6Vulic D,Lee BT,Dede J,et al.Extent of control of cardiovascular risk factors and adherence to recommended therapies in US multiethnic adults with coronary heart disease:From a 2005-2006 National Survey[J].Am J Cardiovasc Drugs,2010;10(2):109-14.
7Holme I,Tonstad S,Sogaard AJ,et al.Leisure time physical activity in middle age predicts the metabolic syndrome in old age:results of a 28-year follow-up of men in the Oslo study[J].BMC Public Health,2007;7:154.
8Wu BJ,Kathir K,Witting PK,et al.Antioxidants protect from atherosclerosis by a heme oxygenase-1 pathway that is independent of free radical scavenging[J].J Exp Med,2006;203(4):1117-27.
4Sandhofer A, Tatarczyk T, Laimer M, et al. The TaqlB-variant in the chol-esterylester transferprotein gene and the risk ofmetabolic syndrome [ J ]. Obesity ( SilverSpring ), 2008,16 ( 4 ) :919 -922.
5Tall AR. Plasma cholesteryl ester transfer protein [ J ]. J Lipid Res, 1993,34(8) :255-274.
6Delilah Z, David J. A genome-wide association study of the metabolic syndrome in indian asian men[J]. PLoS ONE, 2010,5 (8) : 1196.
7Dullaart RP, Sluiter WJ. Common variation in the CETPgene and the im-plications for cardiovasculardisease and its treatment: an up- dated analysis[J]. Pharmacogenomics, 2008,9 (6) :747-756.
8Inazu A, Jiang XC, Haraki T, et al. Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol [J]. J CIin Invest, 1994,94(5) :1872-1882.
9Kato N, Miyata B, Tabara T, et al. High-density association study and nomination of susceptibility genes for hypertension in the Japanese National Project [ J ]. Hum Mol Genet, 2008,17 (4) : 617-627.
10Sandhofer A,Tatarczy K T, Laimer M, et al. The TaqIB- variant in the chol-esterylester transferprotein gene and the risk ofmetabolic syndrome[J]. Obesity (SilverSpri- ng),2008,16(4) : 919-922.
